Confocal Endomicroscopy of Colorectal Polyps by Ussui, Vivian M. & Wallace, Michael B.
Hindawi Publishing Corporation
Gastroenterology Research and Practice




VivianM. Ussui andMichaelB. Wallace
Department of Gastroenterology, Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL 32224, USA
Correspondence should be addressed to Michael B. Wallace, wallace.michael@mayo.edu
Received 6 October 2011; Accepted 21 October 2011
Academic Editor: Giovanni D. de Palma
Copyright © 2012 V. M. Ussui and M. B. Wallace. This is an open access article distributed under the Creative Commons
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is
properly cited.
Confocal laser endomicroscopy (CLE) is one of several novel methods that provide real-time, high-resolution imaging at a micron
scale via endoscopes. CLE has the potential to be a disruptive technology in that it can change the current algorithms that depend
on biopsy to perform surveillance of high-risk conditions. Furthermore, it allows on-table decision making that has the potential
to guide therapy in real time and reduce the need for repeated procedures. CLE and related technologies are often termed “virtual
biopsy” as they simulate the images seen in traditional histology. However, the imaging of living tissue allows more than just
pragmatic convenience; it also allows imaging of living tissue such as active capillary circulation, cellular death, and vascular and
endothelial translocation, thus extending beyond what is capable in traditional biopsy. Immediate potential applications of CLE
are to guide biopsy sampling in Barrett’s esophagus and inﬂammatory bowel disease surveillance, evaluation of colorectal polyps,
and intraductal imaging of the pancreas and bile duct. Data on these applications is rapidly emerging, and more is needed to
clearly demonstrate the optimal applications of CLE. In this paper, we will focus on the role of CLE as applied to colorectal polyps
detected during colonoscopy.
1. Purpose of Paper
The purpose of the paper is to assess the importance of
probe-based confocal endomicroscopy on colorectal polyps
with a particular emphasis on distinguishing hyperplastic
from neoplastic polyps.
2.Recent Findings
New endoscopic imaging modalities have emerged within
the past few years and have created a new concept towards
diagnosis. Recently, we have seen the evolution of endoscopy
from high-deﬁnition white light endoscopy and color-
enhancement methods, to the novel electronic optical tech-
nology known as “virtual biopsy,” with increased magni-
ﬁcation now approaching that of light microscopy. Color-
enhancement methods include chromoendoscopy with top-
ical dyes, narrow-band imaging (NBI), autoﬂuorescence
endoscopy, Raman spectroscopy probes, and trimodal spec-
troscopy [1].
Also, Fujinon intelligent color enhancement (FICE) and
iScan (Pentax) are examples of computed virtualchromoen-
doscopy imaging, both diﬀerent from NBI, which do not
depend on optical ﬁlters [2].
Confocal laser endomicroscopy (CLE) allows real-time
imaging of the GI tract at approximately 1000-fold magni-
ﬁcation with resolution of approximately 1 micron. At this
level, visualization of mucosa and lamina propria, as well as
single cells is achievable with real-time acquisition speeds
[3, 4].
A standard classiﬁcation system has been developed for
both eCLE, termed the Mainz classiﬁcation [3], and for
pCLE, termed the “Miami” classiﬁcation [5]. These systems
distinguished neoplastic from hyperplastic polyps of the
colon based on a dark, irregularly thickened epithelial layer
characteristic of epithelial dysplasia.
3.Introduction
Colorectal cancer (CRC) is the fourth most commonly di-
agnosed cancer among men and women and ranks as2 Gastroenterology Research and Practice
the second most common cause of death from cancer in the
United States [6, 7].
The importance of colonoscopy with polypectomy to
reduce colorectal mortality is well known [8].
The primary purpose of colonoscopy is to identify pre-
cancerous polyps and remove them before they become ma-
lignant. Extensive studies have identiﬁed adenomatous pol-
yps (and some serrated polyps) as the primary precursor of
colorectal cancer. Other polyps such as small hyperplastic
polyps especially those in the distal colon have little malig-
nant potential. A fundamental limitation of colonoscopy is
that, until recently, the only method to reliably diagnose
adenomatous and hyperplastic polyp was to remove them
and examine them histologically. This reliance on histology
implies that there is an undesirable cost and a small risk of
removing polyps with little neoplastic risk.
Hyperplastic polyps represent around one-third to one-
half of all the polyps [9, 10]. Also of importance are the ser-
rated adenomas. These types of adenomas are manifested in
two varieties: traditional serrated adenoma typically assum-
ing a polypoid appearance and the sessile serrated adenoma,
ﬂat or slightly raised and located on the proximal colon. This
type of adenoma presents some molecular features diﬀerent
from the other colon adenomas and might develop a malig-
nant presentation through a so-called “serrated neoplasia
pathway [11].”
Although the absolute risk of polypectomy is small, it is
still the most important cause of complication of colono-
scopy [12]. Because of the increasing ability to distinguish
hyperplastic and neoplastic polyps in vivo, as well as the
increasing cost of pathologic examination of all polyps, the
concept of using in vivo diagnosis to direct polypectomy has
emerged. There are two potential applications of this: ﬁrst,
direct polypectomy only to neoplastic (and serrated) polyps
and leave small, low-risk hyperplastic polyps in situ. The
second application, termed “diagnose and discard,” relies on
in vivo diagnosis of low-risk adenomas followed by resection
without further histology.
Considering the information above about colon polyp
characteristics with one-third to one-half of these polyps
being hyperplastic, smaller than 10mm, and with very low
likelihood of malignancy potential [10], selecting the right
polyps to remove is of utmost importance. This has the
potential to reduce the risk of complications, eliminate
unnecessary costs for histopathology analysis, and save time
when making a decision for the patient’s treatment. Several
groups, including the American Society for Gastrointestinal
Endoscopy (ASGE), have provided guidelines for when it
would be clinically acceptable to adopt a virtual biopsy
approach. They set clear thresholds for the accuracy that
must be achieved (at least 90% negative predictive value for
adenomatouspolypsandatleast90%accuracyforpredicting
the correct surveillance interval). They also set clear target
lesions (small distal polyps) that are both the most common
polyps as well as those at lowest risk of malignant degenera-
tion in the unlikely event that an incorrect diagnosis is made
[13].
Many advanced endoscopic imaging techniques, includ-
ing dye-based chromoendoscopy and digital chromoendos-
copy, have been carefully studied with these goals in mind.
Some impractical aspects of dye-based chromoendosco-
p y ,s u c ha sl o n g e rp r o c e d u r et i m e s ,d i ﬀerent dyestainings,
and washing techniques, contributed to its limited applica-
tion. Although these factors do not aﬀect the “virtual” chro-
moendoscopy methods, such as narrow-band imaging (NBI)
or Fujinon intelligent colon enhancement (FICE), an exten-
sivereviewbytheASGEonthesemethodsshowsmodestand
variable accuracy [13]. CLE has also been extensively studied
with regard to colorectal polyps [3, 4].
4. Confocal Systems/Methods
There are currently two clinically available CLE systems; one
that is integrated into a Pentax endoscope (eCLE) with the
confocal imaging window located at the distal tip of the
endoscope. This system allows resolution of approximately
0.8 microns, as well as variable depth of focus from the
surface of the lens (0 microns) to a depth of 250 microns by
using a control built into the endoscope handle. Still images
are obtained at approximately 1 per second.
Thesecondsystemisbasedonathrough-the-scopeprobe
(pCLE), produced by Mauna Kea Technologies. With pCLE,
the laser scanning unit is mounted outside the endoscope,
and a bundle of optical ﬁber, approximately 2.5mm in
diameter, delivers light and collects the images. Proprietary
algorithms correct for image distortion of the long ﬁber
bundle. The pCLE system has slightly less resolution (1
micron) and a ﬁxed imaging depth (50 microns); but allows
for faster video-rate scanning (12 frames per second) and
a far greater versatility with any endoscopic system, includ-
ing cholangioscopy, through the needle probes for intra-
tumor/intracystic imaging and other non-GI endoscopes
(cystoscopy, bronchoscopy, etc.).
4.1. Clinical Image Acquisition. All CLE imaging systems are
optimized by a contrast agent, such as ﬂuorescein sodium,
discussed in detail below. The quality of the image is aﬀected
by several technical factors such as the timing of injection,
probe position, and probe stability.
The optimal timing of imaging is obtained within the
ﬁrst 8–10 minutes after contrast injection, although accept-
able imaging can be obtained for up to 60 minutes after
injection [14]. In order to minimize tissue and vascular leak
artifact, the probe should be placed gently in direct contact
with the tissue without pressure or trauma.
The probe should be as perpendicular to the mucosa as
possible.Thiscanbechallengingintheesophagus.Maintain-
ing probe stability is critical to good image acquisition. With
the eCLE system, suction is applied to the tissue immediately
adjacent to the target lesion to hold the image steady. With
pCLE, using the free-hand method can be challenging, but
is facilitated by use of a clear 4mm cap on the tip of the
endoscopewithslightsuction,whichcanhelpkeeptheprobe
in the proper site.Gastroenterology Research and Practice 3
Table 1: Colorectal pathology prediction using confocal pattern classiﬁcation.
Grade Vessel architecture Crypt architecture
Normal Hexagonal, honeycomb appearance Regular luminal openings, homogenous layer of
epithelial cells
Regeneration Hexagonal, honeycomb appearance with no or mild increase
in the number of capillaries
Star-shaped luminal crypt openings or focal aggregation
of regular-shaped crypts with a regular or reduced
amount of goblet cells
Neoplasia Dilated and distorted vessels; irregular architecture with little
or no orientation to adjunct tissue
Ridged-lined irregular epithelial layer with loss of crypts
and goblet cells; irregular cell architecture with little or
no mucin
Table 2: Systematic classiﬁcation of colorectal lesions (eCLE based).
General architecture Cytonuclear features
Normal mucosa
Regular (uniform) architecture of surface and
glandular epithelium
Epithelial cells are uniformly lined up along the
basement membrane
Regular “honey-comb” appearance of vascular pattern
Normal cell polarity of surface and glandular
epithelium, normal aspect of mucin-producing
goblet cells
Nonadenomatous polyps
Slightly disturbed architecture: enlarged, branch-like,
elongated crypts
Epithelial cells are morphologically normal,
p r e s e r v e dc e l lp o l a r i t y
Increased number of cells in the crypts Depletion of goblet cells
Mild alterations of vascular pattern
Inﬂammatory inﬁltrate of lamina propria, decreased
crypt/stroma ratio
Adenomatous polyps
Disturbed architecture: mild irregularity of the crypts,
eventual villous transformation, increased
crypt/stroma ratio, crypt destruction
Incomplete to lack of epithelial surface
maturation
Mild to moderate alterations of vascular pattern Slightly cytonuclear atypia
Islands of malignant cells
Previouslypublished studieswitheCLEhaveused topical
acriﬂavine dye, but its use has been diminished as a
consequence of the possibility of damage to the DNA cells.
Alternately, ﬂuorescein, a relatively inexpensive and safe
contrast agent already approved by the FDA for diagnostic
angiography and angioscopy of the retina, has been com-
monly used during pCLE procedures. It can be used topically
and intravenously with an excellent safety proﬁle [15].
One to ﬁve mL intravenous injection of a 10% solution
enables the visualization of each cell, intensely contrasting
the capillary network [14, 16, 17]. The initial images in the
ﬁrst 10–30 seconds are predominantly vascular; however as
ﬂuoresceinleaks into the extravascularspace, epithelium and
stromal tissues are visualized. Neoplasia tissue appears as
dark epithelial cells, which could be explained by the lack of
ﬂuorescein absorption, accelerated expulsion from the cell,
or greater leakage into the lamina propria [5].
Thelackofdirectnuclearvisualizationdoesnotallowthe
comparison between nucleus and cytoplasm and, therefore,
cannot be used for diagnosis and grading intraepithelial
malignancies [18]. However, the contrast of the dark color
of the neoplastic epithelium permits architectural analysis
of the surface mucosa and aids in diﬀerentiating normal
mucosa from neoplastic tissue [19].
The major side eﬀects of ﬂuorescein are temporary, last-
ing up to 24 hours and consist of skin discoloration and
Table 3: Potential applications of pCLE or CLE.
Areas that have been well
evaluated
Barrett’s esophagus guide to biopsy
Colon polyp classiﬁcation





Experimental areas Solid and cystic tumor imaging
Gastric neoplasia
a yellowish tint to the urine. Other complications include
nausea, hypotension, and mild skin rash. Serious compli-
cations, such as anaphylaxis or infection site reactions, are
extremely rare [15].
4.2. Grading Confocal Images. The Mainz criteria, developed
by Kiesslich et al. [3] in 2004, described patterns of normal,
regenerative, and neoplastic tissue as seen by eCLE (Table 1).
Sanduleanu et al. [20] further deﬁned the key patterns in
colorectal polyps (Table 2).
Finally, the Miami classiﬁcation system, which is similar
to the Mainz system, was developed speciﬁcally for pCLE







Figure 1: Normal colon epithelium. (a) Mosaic image of normal crypts, which are circular and evenly distributed. Although the epithelium
isrelativelydarkcomparedtothebrightstroma,thethicknessisveryregularwithuniformcryptstructures.(b)Singlecryptopening,slightly
slit-like but with abundant goblet structures (dark “dots” within the epithelial cells). (c) Capillary vasculature typically seen very early in the
injection. The vessels are small (<10mm) in diameter and form a regular capillary network.
20µm
Figure 2: Adenomatous polyps. The epithelium is much darker
with irregular thickness and forming small villous-like structures
with wide openings.
shown in Figures 1(a)–1(c). Examples of colonic adenomas
and hyperplastic polyps are shown in Figures 2 and 3.
5. ClinicalApplication
5.1. Colon Polyps. The following methods have been applied
to predict histology based on the Kudo pit pattern, vascular
pattern intensity (VPI), and color: Chromoendoscopy (CE),
narrow-band imaging (NBI) and a combination of NBI and
autoﬂuorescence imaging (AFI) called endoscopic trimodal
Figure 3: Hyperplastic polyp. The crypt opening is stellate in shape
similar to Kudo type 2 pit patterns. The epithelium is relatively
bright and regular in thickness.
imaging(ETMI),andCLE.RegardingcolonpolypsandCLE,
themostsigniﬁcantreasonforitsapplicationisthecapability
of discerning a hyperplastic from an adenomatous polyp.
The ﬁrst report of the use of endoscope-based CLE was
published by Kiesslich et al. [3]. Their study of 42 patients
has proven the ability to predict the presence of neoplastic
alterations with a very high degree of accuracy (sensitivity,
97.4%; speciﬁcity, 99.4%; accuracy, 99.2%).
De Palma et al. [21] further reported the accuracy and
interobserver agreement for pCLE in colorectal polyps. In
a study involving 32 small polyps in 20 patients rangingGastroenterology Research and Practice 5
from 1 to 9mm, comparing pCLE and NBI, pCLE achieved
a sensitivity and negative predictive value of 100% and
speciﬁcity of 85% in predicting adenomatous histology.
Our group recently reported a comparison of pCLE to
virtualchromoendoscopy(NBIorFICE).SensitivityofpCLE
washigherthanvirtualchromoendoscopy(91%versus77%)
P = 0.01 with similar speciﬁcity (76% versus 71%). When
looking at subgroups of polyps imaged NBI versus FICE, the
advantage of pCLE was only seen in comparison to FICE
imaging with statistically similar accuracy when compared
to NBI [22]. This study included both large (>9mm) and
small polyps. Therefore, our group has further explored the
accuracy of pCLE, whereas NBI focused exclusively on the
small polyps that may be eligible for a diagnose-and-discard
strategy. In this study, pCLE and NBI were evaluated both
independently and in combination.
One hundred and thirty polyps <10mm were evaluated
in 65 patients. pCLE had a higher sensitivity than NBI (86%
versus 64%, P 0.008) but with lower speciﬁcity (78% versus
92%,P 0.027)andsimilaroverallaccuracy.Whencombining
pCLE and NBI, limiting the analysis to high-conﬁdence
images, the sensitivity and negative predictive value was 94%
and speciﬁcity 97%. This is important as it demonstrates the
technology can exceed the ASGE recommended thresholds
(90% or greater) for acceptance of a diagnose-and-discard
strategy [23].
The previous trials of both eCLE and pCLE have largely
evaluated oﬄine image interpretation, which does not allow
on-table decision such as diagnose and discard. Our group
hasrecentlycomparedreal-timeandoﬄinepCLEinterpreta-
tions of colorectal lesions. Although real-time interpretation
accuracy was slightly lower (78% versus 81%), these diﬀer-
ences were statistically equivalent [23, 24].
AnarticleassessingthelearningcurveofinvivopCLEfor
prediction of colorectal neoplasia indicated that a wide range
of GI specialists could become proﬁcient in interpreting
high-quality pCLE images after review of 50–70 cases and
approximately 2 hours of training [9].
6. Conclusion
Confocal laser endomicroscopy has brought several insights
andnewconcepts totheendoscopic ﬁeld. Considering allthe
advantages and drawbacks, it is important to highlight a few
aspects.
(1) Though the learning curve does not appear to be
long, some training is required to achieve a consis-
tently high level of accuracy.
(2) The combination of virtual chromoendoscopy, such
as NBI and CLE, has proven to be a highly accurate
method for in vivo diagnosis, allowing a careful vir-
tual panchromocolonoscopy followed by target en-
domicroscopic examination.
(3) pCLE has shown higher sensitivity but similar speci-
ﬁcity compared to NBI for small polyps, especially
those sized 1–5mm.
(4) Although promising, the cost of CLE is still high
relative to histology. In order to become more clini-
callyrelevant,thecostmustbereducedthroughmore
durable, less expensive probes and integrated endo-
scopic devices.
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